LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival

Cited by papers we hold 3

• Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy · 2023
  Corrected
• Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis · 2020
  No notice
• Sarcoma treatment in the era of molecular medicine · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.